These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 1835658

  • 1. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia.
    Näsman B, Olsson T, Bäckström T, Eriksson S, Grankvist K, Viitanen M, Bucht G.
    Biol Psychiatry; 1991 Oct 01; 30(7):684-90. PubMed ID: 1835658
    [Abstract] [Full Text] [Related]

  • 2. Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's disease and vascular dementia.
    Bicíková M, Rípová D, Hill M, Jirák R, Havlíková H, Tallová J, Hampl R.
    Clin Chem Lab Med; 2004 May 01; 42(5):518-24. PubMed ID: 15202788
    [Abstract] [Full Text] [Related]

  • 3. Dehydroepiandrosterone sulphate (DHEAS) in the oldest old, aged 85 and over.
    Birkenhäger-Gillesse EG, Derksen J, Lagaay AM.
    Ann N Y Acad Sci; 1994 May 31; 719():543-52. PubMed ID: 8010622
    [Abstract] [Full Text] [Related]

  • 4. Serum dehydroepiandrosterone sulfate levels as an individual marker.
    Thomas G, Frenoy N, Legrain S, Sebag-Lanoe R, Baulieu EE, Debuire B.
    J Clin Endocrinol Metab; 1994 Nov 31; 79(5):1273-6. PubMed ID: 7962319
    [Abstract] [Full Text] [Related]

  • 5. Relationships between dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels and everyday memory in Alzheimer's disease patients compared to healthy controls.
    Carlson LE, Sherwin BB, Chertkow HM.
    Horm Behav; 1999 Jun 31; 35(3):254-63. PubMed ID: 10373337
    [Abstract] [Full Text] [Related]

  • 6. The effect of dehydroepiandrosterone sulfate administration to patients with multi-infarct dementia.
    Azuma T, Nagai Y, Saito T, Funauchi M, Matsubara T, Sakoda S.
    J Neurol Sci; 1999 Jan 01; 162(1):69-73. PubMed ID: 10064172
    [Abstract] [Full Text] [Related]

  • 7. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia.
    Yanase T, Fukahori M, Taniguchi S, Nishi Y, Sakai Y, Takayanagi R, Haji M, Nawata H.
    Endocr J; 1996 Feb 01; 43(1):119-23. PubMed ID: 8732462
    [Abstract] [Full Text] [Related]

  • 8. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease.
    Zaman Z, Roche S, Fielden P, Frost PG, Niriella DC, Cayley AC.
    Age Ageing; 1992 Mar 01; 21(2):91-4. PubMed ID: 1575097
    [Abstract] [Full Text] [Related]

  • 9. Dehydroepiandrosterone sulfate in a long-term care aged population.
    Legrain S, Berr C, Frenoy N, Gourlet V, Debuire B, Baulieu EE.
    Gerontology; 1995 Mar 01; 41(6):343-51. PubMed ID: 8586291
    [Abstract] [Full Text] [Related]

  • 10. Role of DHEA and DHEA-S in Alzheimer's disease.
    Adinoff B, Martin PR, Eckardt MJ, Linnoila M.
    Am J Psychiatry; 1993 Sep 01; 150(9):1432-3. PubMed ID: 8352366
    [No Abstract] [Full Text] [Related]

  • 11. Platelet benzodiazepine binding in Alzheimer's disease.
    Bidder M, Ratzoni G, Weizman A, Blumensohn R, Norymberg M, Tyano S, Gavish M.
    Biol Psychiatry; 1990 Oct 01; 28(7):641-3. PubMed ID: 2171687
    [No Abstract] [Full Text] [Related]

  • 12. Prolactin responses to thyrotropin-releasing hormone in multi-infarct dementia and senile dementia of the Alzheimer type.
    Bille A, Olafsson K, Jensen HV, Andersen J.
    Acta Psychiatr Scand; 1991 May 01; 83(5):321-3. PubMed ID: 1906673
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein E genotypes and serum lipid levels in Alzheimer's disease and multi-infarct dementia.
    Wieringa GE, Burlinson S, Rafferty JA, Gowland E, Burns A.
    Int J Geriatr Psychiatry; 1997 Mar 01; 12(3):359-62. PubMed ID: 9152721
    [Abstract] [Full Text] [Related]

  • 14. Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia.
    Murialdo G, Barreca A, Nobili F, Rollero A, Timossi G, Gianelli MV, Copello F, Rodriguez G, Polleri A.
    J Endocrinol Invest; 2001 Mar 01; 24(3):139-46. PubMed ID: 11314741
    [Abstract] [Full Text] [Related]

  • 15. Alzheimer's disease: pathophysiological implications of measurement of plasma cortisol, plasma dehydroepiandrosterone sulfate, and lymphocytic corticosteroid receptors.
    Armanini D, Vecchio F, Basso A, Milone FF, Simoncini M, Fiore C, Mattarello MJ, Sartorato P, Karbowiak I.
    Endocrine; 2003 Nov 01; 22(2):113-8. PubMed ID: 14665714
    [Abstract] [Full Text] [Related]

  • 16. Cortisol and dehydroepiandosterone sulfate plasma levels and their relationship to aging, cognitive function, and dementia.
    de Bruin VM, Vieira MC, Rocha MN, Viana GS.
    Brain Cogn; 2002 Nov 01; 50(2):316-23. PubMed ID: 12464198
    [Abstract] [Full Text] [Related]

  • 17. Decreased dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) concentrations in plasma of Alzheimer's disease (AD) patients.
    Aldred S, Mecocci P.
    Arch Gerontol Geriatr; 2010 Nov 01; 51(1):e16-8. PubMed ID: 19665809
    [Abstract] [Full Text] [Related]

  • 18. Age and sex differences of dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels in normal controls and Alzheimer's disease (AD).
    Leblhuber F, Neubauer C, Peichl M, Reisecker F, Steinparz FX, Windhager E, Dienstl E.
    Psychopharmacology (Berl); 1993 Nov 01; 111(1):23-6. PubMed ID: 7870929
    [Abstract] [Full Text] [Related]

  • 19. Antiglucocorticoid effects of DHEA-S in Alzheimer's disease.
    Leblhuber F, Windhager E, Neubauer C, Weber J, Reisecker F, Dienstl E.
    Am J Psychiatry; 1992 Aug 01; 149(8):1125-6. PubMed ID: 1344027
    [No Abstract] [Full Text] [Related]

  • 20. Dehydroepiandrosterone sulphate in critical illness: effect of dopamine.
    Van den Berghe G, de Zegher F, Wouters P, Schetz M, Verwaest C, Ferdinande P, Lauwers P.
    Clin Endocrinol (Oxf); 1995 Oct 01; 43(4):457-63. PubMed ID: 7586621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.